ALMKT:EPA
Mauna Kea Technologies SA
€ 0.092
arrow_upward
+1.43%(+0.0013) Siku 1
17 Nov, 17:35:06 GMT +1 · EUR
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya ALMKT...
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
18.30M
Wastani wa kiasi cha mauzo
elfu 478.35
Kiasi cha mauzo ya hisa
elfu 396.59
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Fungua
€ 0.09
Juu
€ 0.09
Chini
€ 0.09
Mtaji wa soko
18.30M
Wastani wa kiasi cha mauzo
elfu 478.35
Kiasi cha mauzo ya hisa
elfu 396.59
Uwiano wa bei ya hisa na mapato kwa kila hisa
0.79
Juu kwa wiki 52
€ 0.23
Chini kwa wiki 52
€ 0.07
EPS
€ 0.12
Hisa za wawekezaji
195.26M
Idadi ya wafanyakazi
56
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Fox Business
·
dakika 49 zilizopita
S&P 500 decline driven by semiconductor confidence issues, says Scott Chronert
MarketWatch
·
dakika 23 zilizopita
The S&P 500 is testing a key technical floor. Is it time to buy, or brace for a bear market?
MarketWatch
·
dakika 20 zilizopita
Only two ‘Magnificent Seven’ stocks have managed to beat the S&P 500 since the start of 2025
Traders Union
·
dakika 50 zilizopita
Bitcoin-to-S&P 500 ratio holds trendline support, James Van Straten notes
Wasifu
Mauna Kea Technologies is a global medical device company focused on endomicroscopy, the field of microscopic imaging during endoscopy procedures. The company researches, develops and markets tools to visualize, detect, and rule out abnormalities including malignant and pre-malignant tumors or lesions in the gastrointestinal and pulmonary tracts.
The company makes Cellvizio, a probe-based Confocal Laser Endomicroscopy system, which provides physicians and researchers with real-time access to histological information during standard endoscopy procedures through high-resolution cellular imaging of internal tissues.
Cellvizio is used in medical applications such as gastrointestinal endoscopy, pulmonology and urology to help physicians diagnose lesions and make accurate treatment decisions in real-time.
Cellvizio went public in July 2011 and trades on the Euronext Paris exchange. Wikipedia
Kuhusu Mauna Kea Technologies SA
Afisa Mkuu Mtendaji (CEO)Sacha Loiseau
Wafanyakazi56
Lilianzishwa2000
Makao makuu-
SektaHealth Care
Sekta-
Tovutimaunakeatech.com